Dimensional Fund Advisors
KPRX icon

Dimensional Fund Advisors’s Kiora Pharmaceuticals KPRX Stock Holding History

Dimensional Fund Advisors’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,362
Closed -$40.9K – 3498
2023
Q1 		$40.9K Buy
+1,362
New +$50.9K ﹤0.01% 3401

Other funds holding KPRX

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Dimensional Fund Advisors's KPRX Position: Q2 2023 in Review

Dimensional Fund Advisors sold out of Kiora Pharmaceuticals (KPRX) in Q2 2023, closing a stake of 1,362 shares — an estimated $40.9K sold.

Dimensional Fund Advisors first reported a position in KPRX in Q1 2023 and held it in 1 quarter. The position peaked at $40.9K in Q1 2023. 17 funds tracked by Wall St. Rank hold KPRX as of Q2 2023.

  • Dimensional Fund Advisors reported no remaining Kiora Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 1,362 Kiora Pharmaceuticals shares in Q2 2023, an estimated $40.9K.
  • Dimensional Fund Advisors first reported a position in Kiora Pharmaceuticals in Q1 2023 and held it in 1 quarter.
  • Dimensional Fund Advisors's Kiora Pharmaceuticals position peaked at $40.9K in Q1 2023.
  • 17 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2023.

Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.